Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

396 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project.
Monfort A, Cardoso E, Eap CB, Fischer Fumeaux CJ, Graz MB, Morisod Harari M, Weisskopf E, Gandia P, Allegaert K, Nordeng H, Hascoët JM, Claris O, Epiney M, Csajka C, Guidi M, Ferreira E, Panchaud A. Monfort A, et al. Among authors: cardoso e. Front Psychiatry. 2023 May 18;14:1167870. doi: 10.3389/fpsyt.2023.1167870. eCollection 2023. Front Psychiatry. 2023. PMID: 37275991 Free PMC article.
Therapeutic drug monitoring of targeted anticancer therapy.
Decosterd LA, Widmer N, Zaman K, Cardoso E, Buclin T, Csajka C. Decosterd LA, et al. Among authors: cardoso e. Biomark Med. 2015;9(9):887-93. doi: 10.2217/bmm.15.78. Epub 2015 Sep 3. Biomark Med. 2015. PMID: 26333311 Review.
Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland.
Bandiera C, Skrabal Ross X, Cardoso E, Wagner D, Csajka C, Olver I, Patterson P, Suppiah V, Gunn KM, Schneider M. Bandiera C, et al. Among authors: cardoso e. Support Care Cancer. 2022 May;30(5):3655-3659. doi: 10.1007/s00520-021-06710-y. Epub 2022 Jan 7. Support Care Cancer. 2022. PMID: 34993650
Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer.
Courlet P, Cardoso E, Bandiera C, Stravodimou A, Zurcher JP, Chtioui H, Locatelli I, Decosterd LA, Darnaud L, Blanchet B, Alexandre J, Wagner AD, Zaman K, Schneider MP, Guidi M, Csajka C. Courlet P, et al. Among authors: cardoso e. Pharmaceutics. 2022 Jun 21;14(7):1317. doi: 10.3390/pharmaceutics14071317. Pharmaceutics. 2022. PMID: 35890213 Free PMC article.
Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer.
Rodier T, Puszkiel A, Cardoso E, Balakirouchenane D, Narjoz C, Arrondeau J, Fallet V, Khoudour N, Guidi M, Vidal M, Declèves X, Csajka C, Alexandre J, Cadranel J, Fabre E, Wislez M, Goldwasser F, Blanchet B. Rodier T, et al. Among authors: cardoso e. Pharmaceutics. 2022 Sep 1;14(9):1844. doi: 10.3390/pharmaceutics14091844. Pharmaceutics. 2022. PMID: 36145591 Free PMC article.
Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study.
Bandiera C, Locatelli I, Courlet P, Cardoso E, Zaman K, Stravodimou A, Dolcan A, Sarivalasis A, Zurcher JP, Aedo-Lopez V, Dotta-Celio J, Peters S, Guidi M, Wagner AD, Csajka C, Schneider MP. Bandiera C, et al. Among authors: cardoso e. Cancers (Basel). 2023 Jan 3;15(1):316. doi: 10.3390/cancers15010316. Cancers (Basel). 2023. PMID: 36612312 Free PMC article.
396 results